| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
07/01/2024 - 12/31/2024
|
|
Authorizing Officer name
|
John
F.X.
Heffernan
|
|
Title
|
Principal
|
|
Business name
|
Park Street Strategies, LLC
|
|
Address
|
121 Mount Vernon Street
|
|
City, state, zip code
|
Boston, MA 02108
|
|
Country
|
US
|
|
Phone
|
617-981-0015
|
|
|
|
|
Client Compensation
|
| Acadia Pharmaceuticals Inc. |
$30,000.00
|
| Acuity Strategic Partners LLC |
$60,000.00
|
| Amgen Inc. |
$36,000.00
|
| Biotechnology Innovation Organization (BIO) |
$27,000.00
|
| Karuna Pharmaceuticals, Inc. |
$30,000.00
|
| Massachusetts Biotechnology Council, Inc. |
$60,000.00
|
| NanoDx, Inc |
$0.00
|
| PTC Therapeutics, Inc. |
$0.00
|
| Sage Therapeutics, Inc. |
$33,000.00
|
| UCB, Inc. |
$22,500.00
|
| Total salaries received |
$298,500.00
|
|
|
| |
|
Compensation/Salaries Paid
|
|
John F.X. Heffernan
|
$104,000.00
|
| Total salaries paid |
$104,000.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| 11/21/2024 |
National Pen Co.
|
Advertising expenses
|
$439.44
|
| 12/16/2024 |
Staples
|
Photocopies, scans
|
$30.70
|
| 12/31/2024 |
Micro Center
|
Computer equipment, supplies
|
$1,319.96
|
| 11/20/2024 |
New England Council
|
Professional dues
|
$1,500.00
|
| 12/20/2024 |
MassBio
|
Professional dues
|
$6,000.00
|
| 12/31/2024 |
Meeting House Office & Retail
|
Internet fees
|
$300.00
|
| 12/19/2024 |
Riley & Dever
|
Legal fees
|
$695.00
|
| 07/17/2024 |
US Postal Service
|
Postage, shipping, delivery
|
$13.09
|
| 12/16/2024 |
Staples
|
Office supplies, equipment
|
$1,728.06
|
| 12/31/2024 |
Meeting House Office & Retail
|
Rent
|
$6,794.34
|
| 12/01/2024 |
State House News
|
Professional subscriptions
|
$3,224.00
|
| 12/31/2024 |
AT&T
|
Telephone, cell phone, handheld
|
$645.86
|
| 12/23/2024 |
Ward & Lawless LLC, LLC, compliance support services
|
Other operating expenses
|
$2,973.75
|
| | | Total operating expenses |
$25,664.20
|
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| 07/17/2024 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$42.00
|
| 07/18/2024 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$42.00
|
| 07/30/2024 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$45.00
|
| 11/12/2024 | Park Street Strategies, LLC |
Travel
|
Boston Common Garage, for parking
|
John Heffernan
|
$30.00
|
| 11/13/2024 | Park Street Strategies, LLC |
Travel
|
PI Alley Garage, for parking
|
John Heffernan
|
$43.00
|
| 11/22/2024 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$50.00
|
| 12/19/2024 | Park Street Strategies, LLC |
Travel
|
Boston Common Garage, for parking
|
John Heffernan
|
$30.00
|
| 12/30/2024 | Park Street Strategies, LLC |
Travel
|
Laz Parking, for parking
|
John Heffernan
|
$40.00
|
| | | | | Total amount |
$322.00
|
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Acuity Strategic Partners LLC
|
|
|
|
Executive
|
Other
|
No lobbying activities conducted.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
PTC Therapeutics, Inc.
|
|
|
|
Executive
|
Other
|
No lobbying activities conducted.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Massachusetts Biotechnology Council, Inc.
|
|
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4620
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Labor and Workforce Development (EOLWD)
|
Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4726
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
753
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4138
|
An Act [sic] the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4789
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4977
|
An Act relative to the Affordable Homes Act
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4999
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4910
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4643
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4600
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4566
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2484
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
5159
|
An act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2492
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4653
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2856
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2209
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4785
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4890
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4601
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2834
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4100
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4707
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2869
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4459
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4804
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
5100
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4486
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
4
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2881
|
An Act enhancing the health care market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4632
|
An Act establishing the Massachusetts Data Privacy Act
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
227
|
An Act establishing the Massachusetts Information Privacy and Security Act
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4722
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2871
|
An Act enhancing the health care market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1180
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4773
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Biotechnology Innovation Organization (BIO)
|
|
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
227
|
An Act establishing the Massachusetts Information Privacy and Security Act
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4722
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2871
|
An Act enhancing the health care market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4459
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4804
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
5100
|
An Act relative to strengthening Massachusetts' economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4601
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2834
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4600
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1180
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4773
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2492
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4653
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2856
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4643
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Office of the Governor
|
Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2209
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4785
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4890
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4566
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2484
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
5159
|
An act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4100
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4707
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
2869
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4109
|
An Act relative to salary range transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4999
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4910
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4620
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Labor and Workforce Development (EOLWD)
|
Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts.
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1356
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4632
|
An Act establishing the Massachusetts Data Privacy Act
|
Neutral
|
$0.00
|
N/A
|
|
Executive
|
Executive Office of Health and Human Services (EOHHS)
|
Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4726
|
An Act relative to the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
753
|
An Act relative to preventing discrimination against persons with disabilities in the provision of health care
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4138
|
An Act [sic] the Affordable Homes Act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4789
|
An Act relative to strengthening Massachusetts’ economic leadership
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4977
|
An Act relative to the Affordable Homes Act
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
4486
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
4
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2881
|
An Act enhancing the health care market review process
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Karuna Pharmaceuticals, Inc.
|
|
|
|
House Bill
|
497
|
An Act relative to the promotion of mental health education
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1246
|
An Act to provide more timely treatment of inpatient mental health care
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
989
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
610
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
240
|
An Act relative to mental health education
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2785
|
An Act to provide more timely treatment of inpatient mental health care
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1248
|
An Act to increase investment in behavioral health care in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Sage Therapeutics, Inc.
|
|
|
|
House Bill
|
2209
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1247
|
An Act ensuring access to addiction services
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2785
|
An Act to provide more timely treatment of inpatient mental health care
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4785
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4487
|
An Act relative to the Massachusetts maternal mortality and morbidity review committee
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1361
|
An Act promoting patient safety and equitable access to care
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3630
|
An Act relative to the Massachusetts maternal mortality and morbidity review committee
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4999
|
An Act promoting access to midwifery care and out-of-hospital birth options
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Acadia Pharmaceuticals Inc.
|
|
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2429
|
An Act relative to gender identity on Massachusetts identification
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency.
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2429
|
An Act relative to gender identity on Massachusetts identification
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2429
|
An Act relative to gender identity on Massachusetts identification
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
3012
|
An Act relative to pharmaceutical access, costs and transparency.
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
House Bill
|
5033
|
An Act to improve quality and oversight of long-term care
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
379
|
An Act to improve quality and oversight of long-term care
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 07/01/2024 | John F.X. Heffernan |
Kevin G. Honan
|
State Representative, 17th Suffolk
|
$200.00
|
| 07/11/2024 | John F.X. Heffernan |
Kim Driscoll
|
Lieutenant Governor, Commonwealth of Massachusetts
|
$200.00
|
| 07/23/2024 | John F.X. Heffernan |
Edward Philips
|
State Representative, 8th Norfolk
|
$200.00
|
| 07/29/2024 | John F.X. Heffernan |
Michael Moran
|
State Representative, 18th Suffolk
|
$200.00
|
| 09/05/2024 | John F.X. Heffernan |
Tram T. Nguyen
|
State Representative, 18th Essex
|
$200.00
|
| 10/01/2024 | John F.X. Heffernan |
Bill MacGregor
|
State Representative, 10th Suffolk
|
$200.00
|
| 11/02/2024 | John F.X. Heffernan |
Brendan Crighton
|
State Senate, Third Essex
|
$200.00
|
| 11/16/2024 | John F.X. Heffernan |
Jennifer Armini
|
State Representative, 8th Essex
|
$200.00
|
| 12/16/2024 | John F.X. Heffernan |
Mike Rush
|
State Senate, Norfolk and suffolk
|
$200.00
|
| 12/31/2024 | John F.X. Heffernan |
Nick Collins
|
State Senate, 1st Suffolk
|
$200.00
|
| | | | Total contributions |
$2,000.00
|
|
|
|
|
|